ÂÜÀòÂÒÂ×

Gloria Lau is an accomplished professional with extensive experience in oncology operations and program leadership, currently serving as Vice President at Alnylam Pharmaceuticals since September 2017. Previous roles at Alnylam include Senior Director positions in Oncology Operations and Program Leadership. Gloria's background also includes significant experience at Alexion Pharmaceuticals as Director of Global R&D Project Management, and at Synageva BioPharma Corporation in various senior director roles. Gloria's earlier career featured leadership positions at AMAG Pharmaceuticals and Genzyme Corporation, where responsibilities included managing cross-functional teams and program activities. Gloria holds an M.B.A. from the Questrom School of Business at Boston University and an M.Sc. in Biochemistry from The University of British Columbia.